{"name":"Arnatar Therapeutics, Inc.","slug":"arnatar-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxNVTVhUnhnclA3a0gxRFpjYTNDYkRESFdPdWg0RDhVRTFjVVZNTjhVQ3hEVEZueGUtWlAyZDFlMUpwQms1czBibGFIdGRKNkUzOE9ONUVBUUpYZWZEb3FOQ1J5cWJqVFVTVFRFWmRzZUJYT0RSRWE5cTdRdE5lUGMyemxNZThmcFMtczdaZXNMUTMwYW5qdGxCWFFfMkJPYzRGa3IyUTJGMm1MWTlCWExZNDBjSFdVT0N6VTFKa2wySDBHYlp4YnFDV0U1dDVtUmtTTWV2MHExTHpaR2hpOE0wVHVLV2c2UTlGZktRbGgxZ0lvbWRjV2tWMlF3WjFSbVFpWUFBUmVCZm53RlI1eFZF?oc=5","date":"2025-10-20","type":"pipeline","source":"GlobeNewswire","summary":"Arnatar Therapeutics Announces Upcoming Presentations at - GlobeNewswire","headline":"Arnatar Therapeutics Announces Upcoming Presentations at","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQalpYTzlhWERKaXEyUGdMcHhMbjQzaVBITWdJRVo4cEVXVndJalVGc2NNYXo3QkthWWpjTFRZei1SMWV3LTF6MTVYNE8wUXBmWHJSSkxyZFRxRmZyaHRSZ1BPWS00WEJ0ZU40WmtCQWp6ZnBKZHcxbDAwOG5qNW1YQ253RGpBeXVVWFhCMmZmZnlFb2V3ektfUHJqSmdLSUpjUHRjLWJHcmxFZlE2bUpBelBFWEMwQVBCei1Hdg?oc=5","date":"2025-09-28","type":"pipeline","source":"MedCity News","summary":"Sanofi Pumps $625M Into Venture Arm to Back Breakthroughs in Early-Stage Startups - MedCity News","headline":"Sanofi Pumps $625M Into Venture Arm to Back Breakthroughs in Early-Stage Startups","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOUnhmS2lpTGcxdmt3TmhMdm1JOGFNaTA4bWFKYVpXWC1JZ3dNb3dUTkRBU1NRTUFSTzNxMmlCUjhneEZzMThSbnVoTGF4WlJxTzljTjhycVhhLVRGdWRTNFQ2QW9BYjJ0Rk1jZW54VV9hUHJ3SURLa3c1eERKYjBkeHgwM1VnMDVkeGEzNEFBUWZXS3lxWFZjdjM5NWR4b1lSY21GQg?oc=5","date":"2025-09-03","type":"regulatory","source":"San Diego Business Journal","summary":"Arnatar Emerges with FDA Designations, $52M Series A - San Diego Business Journal","headline":"Arnatar Emerges with FDA Designations, $52M Series A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOVDdqd2ZwY1FxRUdENEZ0ajJOUE1sbGR6elJKTEN4d1ZILTRHaVplSlFEaTl1Rm9SOFFzdDRNLU1lTjZjMkRseEZNRXk0SGVnLTY2QmNTUENYZWtuR0pqQXhub3pRREVaS1ZJc3lieWtOT2dVQ3g5VXFMM0tRNWZMdnZuNVBra3hRcXBWRFlBWDFIbVlhNDNGbC14NFNNeU1KX3dyNQ?oc=5","date":"2025-08-26","type":"pipeline","source":"BioWorld News","summary":"Arnatar emerges with RNA approach to both silence and restore - BioWorld News","headline":"Arnatar emerges with RNA approach to both silence and restore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE9rOENvZktTWXhGWjBlS21tWDdhdVVJTXJaRkNVekdvWXFmTUxyRGJ6a0xWaU5LbHhMT040U0xCTzZkdmJxUS1yTUFRS3VZZFdVVnhjSXBMMTR0SUp2aHhZQjdR?oc=5","date":"2025-08-26","type":"pipeline","source":"The Pharma Letter","summary":"Arnatar Therapeutics - The Pharma Letter","headline":"Arnatar Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQZlR3WmRUMThOWlNxeWpsU1FPa19TM2xPdGJBa3RHVk9TdWE1eWxaZ3FXM183ajVBUkk5UDcwb1VFYkF3RjVXdWtxclk5THpYNmNESnNyeFp4MmVOMGZSejl5cWlHVGRuUV81ZjQtY01IcGJQMXFfckxBeE9adVJjcmJrTFY1VDQ1Q2poMFEtemNtMUo1S0Y2d29rYTJsMExDUkh2R0xlWFpPcWhXQUNrdElKOW1JMFRjNHRlWGxialk?oc=5","date":"2025-08-26","type":"pipeline","source":"The Pharma Letter","summary":"Arnatar lifts back the curtain to reveal platform and pipeline of RNA therapeutics - The Pharma Letter","headline":"Arnatar lifts back the curtain to reveal platform and pipeline of RNA therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxPejVMS0t2NkpSRkZCMXZGZk9wMlowSk1CN09pTkdvZlgzMElOX25sWG04VFpDdXdoamxOeE9JZkh1THl3QS1tZ2gwLWFiSjdsYUpoMkJsbHBaak5VcEdHdUNiaFRrQUt2OG4yQjUwSHRydW42S0pUb1NuQVdNdkNlUnhxZ1FUTXB4MlBEVFBacWUyc0Q0YTVOTjJYNVRoS0xSQXFaODdJZDFjTnc?oc=5","date":"2025-08-25","type":"pipeline","source":"Fierce Biotech","summary":"Arnatar unveils with $52M, dual-modality RNA platform and rare disease asset - Fierce Biotech","headline":"Arnatar unveils with $52M, dual-modality RNA platform and rare disease asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE0tQVVlWUFOa2VqR3lGVkhQbFRsb2E2a19GclA3NS1mb3N3LUg3N2drOThNQS01eWpJSmhyclFLTjMxXzI3bWdscThEVFgzVGNnUXE4?oc=5","date":"2025-08-25","type":"pipeline","source":"FirstWord Pharma","summary":"San Diego startup debuts with $52M for 'translation-boosting' ASO platform - FirstWord Pharma","headline":"San Diego startup debuts with $52M for 'translation-boosting' ASO platform","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxQdHJJQnluSWVlZEZXbGJLaDc1R0ZfQWxqUjZ1MS1JRTFCNmV4VEpNaV96S0o1ZVVKQUlnRXVDM0ZyTHJTdzdYeTFBeVlIZVdVdVZ2RGZLaEQ5eEIwOWVSR0lDUTRsZ2FMVEh1UTlkWjI2Q3g3QXBjeWg1WU5hWTVnczBlRmNPaWJ6d2NYYlhFd1VaNy1aVzFIX2k3bk1RaXRLcEtncmxsUEJFSGk1YkQtdS0tRFVmQzBhODhsWXpNQ0E2MUFmWWlOU2p4c1dEcWRxdk00WTNmak8yTzM3LTVlMDQ4ZnU0dW1aeGc?oc=5","date":"2025-08-25","type":"pipeline","source":"Citeline News & Insights","summary":"Finance Watch: BeOne Raises $885m In Imdelltra Royalty Sale - Citeline News & Insights","headline":"Finance Watch: BeOne Raises $885m In Imdelltra Royalty Sale - Citeline News & Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiR0FVX3lxTE53TldkSC13ZzVxNlZVNzM0TV9iYVZFb05yY28xZWd2WHhrb3hFZHF6SkNzbFVKc29jOGkxWlBWX0d1MDlmaTVJ?oc=5","date":"2024-07-15","type":"pipeline","source":"BioSpace","summary":"NextGen: Class of 2026 - BioSpace","headline":"NextGen: Class of 2026","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}